Condensed Consolidated Statements of Stockholders' Equity (Statement) - USD ($)
$ in Thousands
Previously Reported
Common Stock
Previously Reported
Treasury Stock
Previously Reported
Additional Paid-in Capital
Previously Reported
Accumulated Deficit
Previously Reported
Revision of Prior Period, Adjustment
Common Stock
Revision of Prior Period, Adjustment
Treasury Stock
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Shares outstanding at beginning of period (in shares) at Dec. 31, 2019 3,681,185         16,945,064     20,626,249        
Total stockholders' equity at beginning of period at Dec. 31, 2019 $ 36 $ (23,453) $ 181,464 $ (72,745) $ 85,302 $ (34) $ 23,453 $ (23,419) $ 2   $ 158,045 $ (72,745) $ 85,302
Stock-based compensation expense and vesting of restricted stock units                     749   749
Net loss                       (2,409) (2,409)
Shares outstanding at end of period (in shares) at Mar. 31, 2020                 20,626,249        
Total stockholders' equity at end of period at Mar. 31, 2020                 $ 2   158,794 (75,154) 83,642
Shares outstanding at beginning of period (in shares) at Dec. 31, 2020 3,681,185         16,945,064     20,626,249        
Total stockholders' equity at beginning of period at Dec. 31, 2020 $ 36 $ (23,453) $ 184,452 $ (78,016) $ 83,019 $ (34) $ 23,453 $ (23,419) $ 2   161,033 (78,016) 83,019
Conversion of convertible promissory note (in shares)                 290,563        
Conversion of convertible promissory note                     2,730   2,730
Business Combination and PIPE financing (in shares)                 12,644,168        
Business Combination and PIPE financing                 $ 1 $ (4,445) 99,299   94,855
Stock-based compensation expense and vesting of restricted stock units                     3,498   3,498
Net loss                       (4,997) (4,997)
Shares outstanding at end of period (in shares) at Mar. 31, 2021                 33,560,980        
Total stockholders' equity at end of period at Mar. 31, 2021                 $ 3 $ (4,445) $ 266,560 $ (83,013) $ 179,105